Compositions for anti-fibrinolytic treatment

摘要

The present invention concerns the use of a neutralizing antibody for matrix metaloproteinase-10 (MMP-10) in the preparation of a medicine useful for anti-fibrinolitic treatment, and for haemorrages and haemorragic complications of various etiologies.